VBI Vaccines New Stock Price, News & Analysis
Company Description
VBI Vaccines New (NASDAQ: VBIV) is a publicly traded biological product (except diagnostic) manufacturing company in the Pharmaceutical Preparations sector. The company has a market capitalization of $1.9M, ranking #6,973 among all listed U.S. companies by market cap.
VBIV stock has declined 98.6% over the past year. Shares last traded at $0.6300.
This page provides a comprehensive overview of VBIV stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
VBI Vaccines New (VBIV) stock last traded at $0.6300. Over the past 12 months, the stock has lost 98.6%. At a market capitalization of $1.9M, VBIV is classified as a micro-cap stock with approximately 28.7M shares outstanding.
Latest News
VBI Vaccines New has 10 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 8 with negative movement. Key topics include clinical trial, earnings, offering. View all VBIV news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
VBIV Company Profile & Sector Positioning
VBI Vaccines New (VBIV) operates in the Biological Product (except Diagnostic) Manufacturing industry within the broader Pharmaceutical Preparations sector and is listed on the NASDAQ.